Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Emtnester isn't this the first PTO rejection of the 336?

Yes it is the first one, that I can see.

As far as being expected, after the second OA on 148 I sure expected one. Plus once a reexam is authorized it usually gets at least on non-final rejection...or otherwise the original examiner, who handled the original request, would have denied the request for reexam if there wasn't something that effected the patent.

JMHO

4
Jul 08, 2008 12:19PM
Share
New Message
Please login to post a reply